Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference32 articles.
1. Levi, M. (2017). Generalism in modern subspecializing medicine. European Journal of Internal Medicine., 39, 36–38.
2. Smit, E. F., Wu, Y. L., Gervais, R., et al. (2016). A randomized, double-blind, phase III study comparing two doses of erlotinib for second-line treatment of current smokers with advanced non-small-cell lung cancer (CurrentS). Lung Cancer., 99, 94–101.
3. Temel, J.S., Gainor, J.F., Sullivan, R.J., Greer, J.A., (2018). Keeping expectations in check with immune checkpoint inhibitors. Journal of Clinical Oncology,Jco2017762146.
4. Berrino, F., De Angelis, R., Sant, M., et al. (2007). Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: results of the EUROCARE-4 study. The lancet Oncology, 8(9), 773–783.
5. Aaronson, N. K., Mattioli, V., Minton, O., et al. (2014). Beyond treatment—Psychosocial and behavioural issues in cancer survivorship research and practice. EJC supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer [et al. ], 12(1), 54–64.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献